Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of determining a chemotherapeutic regimen by assaying gene expression in primary tumors

Method of determining a chemotherapeutic regimen by assaying gene expression in primary tumors

US Patent 8026062 · Granted Sep 27, 2011

Estimated economic value: $753,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

DNA stabilization of RNA2024
Use of circulating cell-free RNA for diagnosis and/or monitoring cancer2023
DNA stabilization of RNA2021
Method of determining a chemotherapeutic regimen based on ERCC1 and TS expressio2013
Process for high-throughput DNA methylation analysis2012
Quantitative measurement of gene expression from fixed paraffin embedded tissue2011
Quantitative measurement of gene expression based on isolation of RNA from forma2011
Method for isolation of DNA, RNA and proteins from formalin-fixed paraffin-embed2011
Method of determining a chemotherapeutic regimen based on ERCC1 and TS expressio2010
Method of determining a chemotherapeutic regimen based on ERCC1 and TS expressio2009
Process for high throughput DNA methylation analysis2009
Method of determining a chemotherapeutic regimen based on glutathione-s transfer2006